PATH EX

Nashville, United States

PATH EX has developed a proprietary technology to selectively separate and capture bacteria and toxins from human blood.

$5.0M raised

May 2025

Venture - Series Unknown

Top Investors

National Science FoundationMassChallengeFitz Gate VenturesInnova MemphisIAG Capital Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has PATH EX raised?

PATH EX has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.

Who are PATH EX's investors?

PATH EX's investors include National Science Foundation, MassChallenge, Fitz Gate Ventures, Innova Memphis, IAG Capital Partners.

Where is PATH EX headquartered?

PATH EX is headquartered in Nashville, United States.

What does PATH EX do?

PATH EX has developed a proprietary technology to selectively separate and capture bacteria and toxins from human blood.

What stage is PATH EX at?

PATH EX is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 8, 2025.

MLA

"PATH EX — Funding & Investors." VCBacked, May 8, 2025, https://www.vcbacked.co/company/path-ex. Accessed June 4, 2026.

APA

VCBacked. (2025). PATH EX — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/path-ex

Wikipedia (cite web)

{{cite web |title=PATH EX — Funding & Investors |url=https://www.vcbacked.co/company/path-ex |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 8, 2025.